Literature DB >> 28245779

Imidazole: An Essential Edifice for the Identification of New Lead Compounds and Drug Development.

Nishtha Shalmali1, Md Rahmat Ali1, Sandhya Bawa1.   

Abstract

In recent years, a drastic rise has been observed in incidences of resistance, low efficacy rates and toxicities to various drugs used in therapeutic application. Presence of imidazole nucleus in several categories of therapeutic agents such as anti-microbials, anti-virals, anti-cancer, etc has made it a vital anchor for the development of new therapeutic agents. Still, there is a need to couple the newest information with the already available knowledge to recognize the present standing of imidazole motif in medicinal chemistry research. In the present review, importance of this nucleus in some less explored activities like anti-malarial and anthelmintic is mentioned along with well explored fields like cancer. Substitution pattern around imidazole nucleus is discussed here with an aim to help medicinal chemists for the development of SAR of imidazole based compounds for each activity. This discussion will further help in the advancement of existing imidazole derivatives and in the generation of new and safe imidazole compounds. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Anti-cancer; antimicrobial; biological activities; drug development; heterocycles; imidazole

Mesh:

Substances:

Year:  2018        PMID: 28245779     DOI: 10.2174/1389557517666170228113656

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress and Delays Proteotoxicity in C. elegans.

Authors:  Natalia Andersen; Tania Veuthey; María Gabriela Blanco; Gustavo Fabian Silbestri; Diego Rayes; María José De Rosa
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

2.  Bromopyrrole Alkaloids with the Inhibitory Effects against the Biofilm Formation of Gram Negative Bacteria.

Authors:  Jingyuan Sun; Jiru Wu; Bang An; Nicole J de Voogd; Wei Cheng; Wenhan Lin
Journal:  Mar Drugs       Date:  2018-01-02       Impact factor: 5.118

3.  Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent.

Authors:  Cristina Campestre; Marcello Locatelli; Paolo Guglielmi; Elisa De Luca; Giuseppe Bellagamba; Sergio Menta; Gokhan Zengin; Christian Celia; Luisa Di Marzio; Simone Carradori
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

4.  Diisopropylphenyl-imidazole (DII): A new compound that exerts anthelmintic activity through novel molecular mechanisms.

Authors:  María Gabriela Blanco; María Soledad Vela Gurovic; Gustavo Fabián Silbestri; Andrés Garelli; Sebastián Giunti; Diego Rayes; María José De Rosa
Journal:  PLoS Negl Trop Dis       Date:  2018-12-17

5.  Binding Study of the Fluorescent Carbazole Derivative with Human Telomeric G-Quadruplexes.

Authors:  Agata Głuszyńska; Bernard Juskowiak; Błażej Rubiś
Journal:  Molecules       Date:  2018-11-30       Impact factor: 4.411

6.  Identification of novel antifungal agents: antimicrobial evaluation, SAR, ADME-Tox and molecular docking studies of a series of imidazole derivatives.

Authors:  Btissam Bouchal; Farid Abrigach; Abdelilah Takfaoui; Manal Elidrissi Errahhali; Mounia Elidrissi Errahhali; Pierre H Dixneuf; Henri Doucet; Rachid Touzani; Mohammed Bellaoui
Journal:  BMC Chem       Date:  2019-08-06

7.  A new FGFR inhibitor disrupts the TGF-β1-induced fibrotic process.

Authors:  Mi-Hyoung Kim; Seung-Youn Jung; Kyung-Hee Song; Jeong-In Park; Jiyeon Ahn; Eun-Ho Kim; Jong Kuk Park; Sang-Gu Hwang; Hee-Jong Woo; Jie-Young Song
Journal:  J Cell Mol Med       Date:  2019-11-06       Impact factor: 5.310

8.  Design and Antioxidant Properties of Bifunctional 2H-Imidazole-Derived Phenolic Compounds-A New Family of Effective Inhibitors for Oxidative Stress-Associated Destructive Processes.

Authors:  Elena L Gerasimova; Elena R Gazizullina; Maria V Borisova; Dinara I Igdisanova; Egor A Nikiforov; Timofey D Moseev; Mikhail V Varaksin; Oleg N Chupakhin; Valery N Charushin; Alla V Ivanova
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.